Implantable graft to close a fistula
View Patent ↗An implantable graft, which may be inserted into a fistula tract to occlude the primary opening of the fistula, is provided. The graft may have a curved, generally conical shape with a trumpet-like head end that continuously tapers to a smaller tail end. The graft may be an integral unit made of a single material, such as a heterograft material. Methods of closing single and multiple fistulae are also provided.
1. A method of treating a fistula of a human patient, the fistula having a tract extending from a first opening in a first body lumen to a second opening, the method comprising
inserting a plug into the first opening of the tract so as to occlude said first opening, wherein the plug comprises non-cellular bioremodelable material that promotes cellular invasion and ingrowth and reconstruction of host tissue within the plug, and wherein the bioremodelable material is selected from the group consisting of a cadaveric material from a human donor and a heterograft material from a non-human donor, and
positioning the plug in the tract whereby the bioremodelable material extends along the fistula tract from the first opening to the second opening and promotes cellular invasion and ingrowth and reconstruction of host tissue within the plug,
wherein the second opening is an opening in a second body lumen or on an exterior surface of the patient.
2. The method of claim 1 , wherein the fistula is selected from the group consisting of: a tracheo-esophageal fistula, a gastro-cutaneous fistula, an anorectal fistula, a recto-vaginal fistula, a recto-vesical fistula, a recto-urethral fistula, a recto-prostatic fistula, a vesico-vaginal fistula and an urethro-vaginal fistula.
3. The method of claim 1 , wherein the bioremodelable material is a collagenous extracellular matrix material.
4. The method of claim 1 , wherein the bioremodelable material is selected from the group consisting of submucosa, small intestinal submucosa, stomach submucosa, urinary bladder submucosa, uterine submucosa, renal capsule membrane, dermal collagen, amnion, dura mater, pericardium, serosa, peritoneum, basement membrane, liver basement membrane and epithelial basement membrane.
5. The method of claim 1 , wherein the bioremodelable material is an intact acellular sheet of a collagenous extracellular matrix material.
6. The method of claim 1 , wherein the bioremodelable material is dermal collagen.
7. The method of claim 1 , wherein the bioremodelable material is submucosa.
8. The method of claim 7 , wherein the submucosa is small intestinal submucosa.
9. The method of claim 1 , wherein the bioremodelable material comprises an intact acellular sheet of dermal collagen or submucosa.
10. The method of claim 1 , wherein the plug further comprises a non-native bioactive.
11. The method of claim 10 , wherein the non-native bioactive and the bioremodelable material are derived from different species.
12. The method of claim 1 , further comprising securing the plug to tissue of the patient adjacent to at least one of the first opening and the second opening.
13. The method of claim 12 , wherein the securing the plug to tissue of the patient comprises suturing the plug to tissue of the patient.
14. The method of claim 1 , further comprising applying a material selected from the group consisting of an adhesive and fibrin glue to the fistula track.
15. The method of claim 1 , wherein the plug comprises a head and a tail, wherein the tail is thinner than the head.
16. A method of treating a fistula of a human patient, the fistula having a tract extending from a first opening to a second opening, the method comprising
inserting a plug into the first opening of the tract so as to occlude said first opening, wherein the plug comprises non-cellular bioremodelable material that promotes cellular invasion and ingrowth and reconstruction of host tissue within the plug, and wherein the bioremodelable material is selected from the group consisting of dermal collagen and submucosa, and
positioning the plug in the tract whereby the bioremodelable material extends along the fistula tract from the first opening to the second opening and promotes cellular invasion and ingrowth and reconstruction of host tissue within the plug,
wherein the first opening is an opening is an opening in a first body lumen the second opening is an opening in a second body lumen or on an exterior surface of the patient.
17. The method of claim 16 , wherein the plug incorporates a non-native bioactive.
18. A method of treating a fistula of a human patient, the fistula having a tract extending from a first opening to a second opening, the method comprising
inserting a plug into the first opening of the tract so as to occlude said first opening, wherein the plug comprises non-cellular bioremodelable material and a non-native bioactive, and wherein the bioremodelable material comprises a collagenous extracellular matrix material, and
positioning the plug in the tract whereby the bioremodelable material extends along the fistula tract from the first opening to the second opening and promotes cellular invasion and ingrowth and reconstruction of host tissue within the plug,
wherein the first opening is an opening is an opening in a first body lumen the second opening is an opening in a second body lumen or on an exterior surface of the patient.
19. The method of claim 18 , wherein the fistula is selected from the group consisting of: a tracheo-esophageal fistula, a gastro-cutaneous fistula, an anorectal fistula, a recto-vaginal fistula, a recto-vesical fistula, a recto-urethral fistula, a recto-prostatic fistula, a vesico-vaginal fistula and an urethro-vaginal fistula.